JPRN-UMIN000002951已完成未知
A pharmaco-kinetic study on TS-1+CDDP+PTXtreatment for advanced and/or metastatic gastric cancer (OGSG 0703 plus) - OGSG 0703
OGSG0 个研究点目标入组 6 人开始时间: 2009年12月28日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 6
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. with fresh bleeding from digestive tract 2. without ability of oral intake due to digestive tract obstruction 3. with history of severe allergy against medicine, especially, Medicines including Polyethylene-caster oil 4. with ascites and/or pleural fluid 5. with severe diseases (infectious diseases, interstitial pneumonia, Pulmonary fibrosis, cardiac dysfunction, renal dysfunction, liver dysfunction, uncontrolled DM etc) 6. with liver cirrhosis and/or jaundice 7. under treatment using psychotrophic agents or with a disease which needs psychological treatment 8. with some symptoms due to brain metastasis 9. with active double cancer 10. pregnant or nursing lady or lady with expectation of pregnancy 11. Any other patient whom the physician in charge of the study judges to be not eligible
研究者
相似试验
已完成
1 期
Phase I study of TS-1+CDDP+PTX therapy in patients with advanced/recurrent gastric cancer (OGSG 0703)Patients with unresectable or metastatic gastric cancerJPRN-UMIN000000903OGSG6
已完成
1 期
A Phase I/II study of combination of TS-1, CDDP plus PTX in patients with advanced/recurrent gastric cancer (OGSG 0703)JPRN-UMIN000002183OGSG40
招募中
不适用
PhaseI/II study of TS-1+CDDP in combination with Radiotherapy with unresectable and locally advanced for biliary tract cancerBiliary tract cancerJPRN-UMIN000007473Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University25
已完成
2 期
Phase II study of preoperative TS-1+CDDP therapy for advanced gastric cancer (OGSG 0004)Patients with unresectable gastric cancer due to limited inavasion or metastasis.JPRN-UMIN000000934OGSG30
已完成
1 期
PhaseI/II study of neoadjuvant TS-1+CDDP with concurrent radiation for biliary tract cancerBiliary tract cancerJPRN-UMIN000009028Keio University School of Medicine40